Published in J Pain Symptom Manage on December 08, 2010
Pain in people living with HIV/AIDS: a systematic review. J Int AIDS Soc (2014) 1.07
HIV-related neuropathy: current perspectives. HIV AIDS (Auckl) (2013) 0.93
The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women. J Neurol Sci (2011) 0.90
Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa. Antivir Ther (2012) 0.88
Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study. Pain (2014) 0.85
Neurology and the Global HIV Epidemic. Semin Neurol (2014) 0.81
Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya. J Neurovirol (2012) 0.80
Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya. J Neurol Sci (2011) 0.79
Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle Nerve (2013) 0.78
Symptomatology of peripheral neuropathy in an African language. PLoS One (2013) 0.77
Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy. PLoS One (2015) 0.75
[Neuropathies related to HIV/AIDS: a clinical study in patients infected with HIV a Centre of Excellence HIV/AIDS of the University of Lubumbashi]. Pan Afr Med J (2015) 0.75
Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs. Pan Afr Med J (2016) 0.75
Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans. Eur J Hum Genet (2014) 0.75
Immune restoration disease after antiretroviral therapy. AIDS (2004) 4.54
An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care (2005) 2.51
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis (2009) 2.24
Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS (2005) 2.06
HIV-associated sensory neuropathies. AIDS (2002) 1.65
Adaptive heterothermy and selective brain cooling in arid-zone mammals. Comp Biochem Physiol B Biochem Mol Biol (2002) 1.62
TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS (2011) 1.51
Elevation of radiolabelled thymidine uptake in RIF-1 fibrosarcoma and HT29 colon adenocarcinoma cells after treatment with thymidylate synthase inhibitors. Eur J Nucl Med Mol Imaging (2006) 1.47
Food handlers' beliefs and self-reported practices. Int J Environ Health Res (2002) 1.47
Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia (2005) 1.45
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One (2010) 1.44
CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells. J Infect Dis (2011) 1.40
A clinical investigation into the microbiological status of 'locally infected' leg ulcers. Int Wound J (2009) 1.40
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. Am J Pathol (2011) 1.22
Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis (2010) 1.19
A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial. Aust J Physiother (2006) 1.18
A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers. Int Wound J (2008) 1.15
Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection. Clin Nutr (2011) 1.14
Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele. J Virol (2006) 1.11
The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Regen (2006) 1.10
Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics (2003) 1.07
Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment. J Infect Dis (2002) 1.07
Knowledge of epilepsy and familiarity with this disorder in the U.S. population: results from the 2002 HealthStyles Survey. Epilepsia (2003) 1.05
Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. Clin Cancer Res (2010) 1.05
Anxiety and self-consciousness in patients with minor facial lacerations. J Adv Nurs (2004) 1.03
Immune restoration disease: a consequence of dysregulated immune responses after HAART. Curr HIV Res (2004) 1.03
Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4+ T cells from HIV-infected patients responding to antiretroviral therapy. Immunol Cell Biol (2006) 1.02
Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev (2004) 1.02
An objective long-term evaluation of Integra (a dermal skin substitute) and split thickness skin grafts, in acute burns and reconstructive surgery. Burns (2009) 1.01
HIV-associated sensory neuropathy: risk factors and genetics. Curr Pain Headache Rep (2012) 0.99
Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2002) 0.99
Reducing wound pain in venous leg ulcers with Biatain Ibu: a randomized, controlled double-blind clinical investigation on the performance and safety. Wound Repair Regen (2009) 0.98
Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function. Clin Immunol (2006) 0.97
Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease. AIDS Res Ther (2008) 0.96
Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study. J Clin Virol (2003) 0.96
Lower extremity ulcers in systemic sclerosis: features and response to therapy. Int J Rheumatol (2010) 0.96
CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 0.95
Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen (2005) 0.95
WebEase: development of a Web-based epilepsy self-management intervention. Prev Chronic Dis (2008) 0.95
Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring. J Clin Microbiol (2009) 0.94
Can we predict neuropathy risk before stavudine prescription in a resource-limited setting? AIDS Res Hum Retroviruses (2008) 0.93
Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk. AIDS Res Hum Retroviruses (2008) 0.93
Quantifying motion for pancreatic radiotherapy margin calculation. Radiother Oncol (2012) 0.93
Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery. J Proteome Res (2012) 0.92
CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or gammadelta T-cells, in HIV patients responding to ART. Immunol Cell Biol (2010) 0.92
Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus. Cell Immunol (2010) 0.92
HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus. AIDS (2005) 0.91
Nurses' attitudes, behaviours and perceived barriers towards pressure ulcer prevention. J Clin Nurs (2004) 0.90
Less pain with Biatain-Ibu: initial findings from a randomised, controlled, double-blind clinical investigation on painful venous leg ulcers. Int Wound J (2007) 0.89
Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer. Int J Radiat Oncol Biol Phys (2008) 0.89
Do interleukin-1 polymorphisms predict the development of periodontitis or the success of dental implants? J Periodontal Res (2002) 0.89
Recovery in functional non-copers following anterior cruciate ligament rupture as detected by gait kinematics. Phys Ther Sport (2008) 0.89
Plantar pressure in off-loading devices used in diabetic ulcer treatment. Wound Repair Regen (2005) 0.89
Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes. Hum Immunol (2004) 0.89
The influence of diabetes and lower limb arterial disease on cutaneous foot perfusion. J Vasc Surg (2006) 0.88
The role of vascular endothelial growth inhibitor in wound healing. Int Wound J (2007) 0.88
Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy. AIDS Res Hum Retroviruses (2006) 0.88
Immunosenescent CD57+CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART. Dis Markers (2011) 0.88
Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection. AIDS (2011) 0.87
The management of deep sternal wound infections using vacuum assisted closure (V.A.C.) therapy. Int Wound J (2006) 0.87
Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy. J Med Virol (2010) 0.87
The international physical activity questionnaire overestimates moderate and vigorous physical activity in HIV-infected individuals compared with accelerometry. J Assoc Nurses AIDS Care (2010) 0.86
Adverse effects of antiretroviral drugs on HIV-1-infected and -uninfected human monocyte-derived macrophages. J Acquir Immune Defic Syndr (2006) 0.86
Minimum daily core body temperature in western grey kangaroos decreases as summer advances: a seasonal pattern, or a direct response to water, heat or energy supply? J Exp Biol (2011) 0.85
Recovery of CD4+ T Cells in HIV patients with a stable virologic response to antiretroviral therapy is associated with polymorphisms of interleukin-6 and central major histocompatibility complex genes. J Acquir Immune Defic Syndr (2006) 0.85
Painful HIV-associated sensory neuropathy. Pain Manag (2012) 0.85
Assessment and management of persistent (chronic) and total wound pain. Int Wound J (2008) 0.85
Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation. AIDS Res Ther (2012) 0.85
A year in the thermal life of a free-ranging herd of springbok Antidorcas marsupialis. J Exp Biol (2005) 0.85
Anxiety and self-consciousness in patients with facial lacerations one week and six months later. Br J Oral Maxillofac Surg (2005) 0.85
Hepatocyte growth factor regulation: an integral part of why wounds become chronic. Wound Repair Regen (2007) 0.83
Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency. Clin Immunol (2010) 0.83
Immunological markers of lung disease due to non-tuberculous mycobacteria. Dis Markers (2010) 0.83
The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial. Int Wound J (2005) 0.83
Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections. J Acquir Immune Defic Syndr (2007) 0.83
First molecular epidemiology study of Mycobacterium tuberculosis in Kiribati. PLoS One (2013) 0.83
The time course of inflammatory cytokine secretion in a rat model of postoperative pain does not coincide with the onset of mechanical hyperalgesia. Can J Physiol Pharmacol (2007) 0.82
High-Density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging. Hum Mutat (2004) 0.82
Restraint increases afebrile body temperature but attenuates fever in Pekin ducks (Anas platyrhynchos). Am J Physiol Regul Integr Comp Physiol (2008) 0.82
Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS (2011) 0.82
Meeting the psychosocial challenges of leg ulceration. Nurs Times (2006) 0.82
Minimising wound-related pain at dressing change: evidence-informed practice. Int Wound J (2008) 0.82
Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART. J Clin Immunol (2006) 0.82
A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA. Nucleic Acids Res (2012) 0.81
Mitochondrial dysfunction in CD4+ lymphocytes from stavudine-treated HIV patients. Mitochondrion (2010) 0.81
Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin. Immunol Cell Biol (2002) 0.81
Why combine a foam dressing with ibuprofen for wound pain and moist wound healing? Int Wound J (2007) 0.81
Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus. Dis Markers (2010) 0.80
Tumour necrosis factor: implications for surgical patients. ANZ J Surg (2006) 0.80
A promoter polymorphism in the central MHC gene, IKBL, influences the binding of transcription factors USF1 and E47 on disease-associated haplotypes. Gene Expr (2004) 0.80
Alleles of the proximal promoter of BAT1, a putative anti-inflammatory gene adjacent to the TNF cluster, reduce transcription on a disease-associated MHC haplotype. Genes Cells (2003) 0.80
Blood flow and Vd (water): both biomarkers required for interpreting the effects of vascular targeting agents on tumor and normal tissue. Mol Cancer Ther (2009) 0.80
Pharmacological treatment of painful HIV-associated sensory neuropathy. S Afr Med J (2015) 0.79